What is the P/E ratio of Genic Co 2024?
The P/E ratio cannot be calculated for Genic Co at the moment.
Own the gold standard ✨ in financial data & analytics
Subscribe for $2 
Overview
Profile
Genic Co Stock stock price, forecast, news, chart, split, dividend and analysis Genic Co ariva, Genic Co onvista, Genic Co finanzen.net, Genic Co aktienfinder, Genic Co marketscreener, Genic Co marketwatch, Genic Co bloomberg, Genic Co handelsblatt, Genic Co wiwo, Genic Co forum
123330.KQ
KR7123330003
Price
Price
3,125.00
Today +/-
+0
Today %
+0 %
Ticker123330.KQ
ISINKR7123330003
P
Genic Co Revenue, EBIT, Net Income KR7123330003 ·
3 years
5 years
10 years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Genic Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Genic Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Genic Co’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Genic Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Genic Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Genic Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Genic Co’s growth potential.
Genic Co Revenue, EBIT and net profit per share
| Date | Genic Co Revenue | Genic Co EBIT | Genic Co Net Income |
|---|---|---|---|
| 2023 | 28.07 B undefined | -4.02 B undefined | -4.41 B undefined |
| 2022 | 31.45 B undefined | -3.17 B undefined | -3.34 B undefined |
| 2021 | 38.41 B undefined | -3.94 B undefined | -4.33 B undefined |
| 2020 | 42.13 B undefined | 1.04 B undefined | -4.35 B undefined |
| 2019 | 43.15 B undefined | -1.15 B undefined | -11.96 B undefined |
| 2018 | 69.03 B undefined | -11.41 B undefined | -15.32 B undefined |
| 2017 | 64.69 B undefined | -8.29 B undefined | -7.47 B undefined |
| 2016 | 89.67 B undefined | 5.36 B undefined | 1.23 B undefined |
| 2015 | 73.71 B undefined | 3.12 B undefined | 2.93 B undefined |
| 2014 | 63.52 B undefined | 1.91 B undefined | 1.96 B undefined |
| 2013 | 62.18 B undefined | 3.87 B undefined | 3.45 B undefined |
| 2012 | 85.81 B undefined | 7.11 B undefined | 5.68 B undefined |
| 2011 | 105.28 B undefined | 13.62 B undefined | 10.52 B undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2011 | 105.28 B KRW | 13.62 B KRW | 10.52 B KRW |
| 2012 | 85.81 B KRW | 7.11 B KRW | 5.68 B KRW |
| 2013 | 62.18 B KRW | 3.87 B KRW | 3.45 B KRW |
| 2014 | 63.52 B KRW | 1.91 B KRW | 1.96 B KRW |
| 2015 | 73.71 B KRW | 3.12 B KRW | 2.93 B KRW |
| 2016 | 89.67 B KRW | 5.36 B KRW | 1.23 B KRW |
| 2017 | 64.69 B KRW | -8.29 B KRW | -7.47 B KRW |
| 2018 | 69.03 B KRW | -11.41 B KRW | -15.32 B KRW |
| 2019 | 43.15 B KRW | -1.15 B KRW | -11.96 B KRW |
| 2020 | 42.13 B KRW | 1.04 B KRW | -4.35 B KRW |
| 2021 | 38.41 B KRW | -3.94 B KRW | -4.33 B KRW |
| 2022 | 31.45 B KRW | -3.17 B KRW | -3.34 B KRW |
| 2023 | 28.07 B KRW | -4.02 B KRW | -4.41 B KRW |
Genic Co Stock Ratios
Simple
Expanded
Income Statement
Balance Sheet
Cashflow
| 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105.28 | 85.81 | 62.18 | 63.52 | 73.71 | 89.67 | 64.69 | 69.03 | 43.15 | 42.13 | 38.41 | 31.45 | 28.07 |
| - | -18.49 | -27.54 | 2.16 | 16.04 | 21.66 | -27.86 | 6.70 | -37.49 | -2.36 | -8.84 | -18.12 | -10.74 |
| 62.07 | 58.03 | 43.88 | 34.90 | 29.20 | 28.21 | 19.06 | 10.87 | 16.64 | 21.59 | 18.01 | 8.58 | 11.52 |
| 65.34 | 49.8 | 27.29 | 22.17 | 21.52 | 25.3 | 12.33 | 7.5 | 7.18 | 9.1 | 6.92 | 2.7 | 3.23 |
| 13.62 | 7.11 | 3.87 | 1.91 | 3.12 | 5.36 | -8.29 | -11.41 | -1.15 | 1.04 | -3.94 | -3.17 | -4.02 |
| 12.94 | 8.28 | 6.22 | 3.01 | 4.23 | 5.98 | -12.81 | -16.53 | -2.66 | 2.47 | -10.27 | -10.09 | -14.33 |
| 10.52 | 5.68 | 3.45 | 1.96 | 2.93 | 1.23 | -7.47 | -15.32 | -11.96 | -4.35 | -4.33 | -3.34 | -4.41 |
| - | -46.02 | -39.21 | -43.34 | 49.54 | -58.12 | -709.55 | 105.21 | -21.95 | -63.60 | -0.53 | -22.86 | 32.04 |
| 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6.86 | 6.86 | 6.86 |
| - | - | - | - | - | - | - | - | - | - | - | - | - |
Details
Keystats
ⓘRevenue and Growth
The Genic Co Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.
Gross Margin
The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.
EBIT and EBIT Margin
EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.
Income and Growth
Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.
Shares Outstanding
Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.
Interpreting Year to Year Comparison
Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.
Expectations and Predictions
Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Genic Co is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.
Genic Co stock margins KR7123330003 ·
The Genic Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Genic Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Genic Co.
3 years
5 years
10 years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Genic Co's sales revenue. A higher gross margin percentage indicates that the Genic Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Genic Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Genic Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Genic Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Genic Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Genic Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Genic Co Margin History
| Genic Co Gross margin | Genic Co Profit margin | Genic Co EBIT margin | Genic Co Profit margin |
|---|---|---|---|
| 2023 | 11.52 % | -14.33 % | -15.71 % |
| 2022 | 8.58 % | -10.09 % | -10.62 % |
| 2021 | 18.01 % | -10.27 % | -11.28 % |
| 2020 | 21.59 % | 2.47 % | -10.33 % |
| 2019 | 16.64 % | -2.66 % | -27.71 % |
| 2018 | 10.87 % | -16.53 % | -22.2 % |
| 2017 | 19.06 % | -12.81 % | -11.54 % |
| 2016 | 28.21 % | 5.98 % | 1.37 % |
| 2015 | 29.2 % | 4.23 % | 3.97 % |
| 2014 | 34.9 % | 3.01 % | 3.08 % |
| 2013 | 43.88 % | 6.22 % | 5.55 % |
| 2012 | 58.03 % | 8.28 % | 6.62 % |
| 2011 | 62.07 % | 12.94 % | 9.99 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2011 | 62.07 % | 12.94 % | 9.99 % |
| 2012 | 58.03 % | 8.28 % | 6.62 % |
| 2013 | 43.88 % | 6.22 % | 5.55 % |
| 2014 | 34.9 % | 3.01 % | 3.08 % |
| 2015 | 29.2 % | 4.23 % | 3.97 % |
| 2016 | 28.21 % | 5.98 % | 1.37 % |
| 2017 | 19.06 % | -12.81 % | -11.54 % |
| 2018 | 10.87 % | -16.53 % | -22.2 % |
| 2019 | 16.64 % | -2.66 % | -27.71 % |
| 2020 | 21.59 % | 2.47 % | -10.33 % |
| 2021 | 18.01 % | -10.27 % | -11.28 % |
| 2022 | 8.58 % | -10.09 % | -10.62 % |
| 2023 | 11.52 % | -14.33 % | -15.71 % |
Genic Co Stock Sales Revenue, EBIT, Earnings per Share KR7123330003 ·
The Genic Co earnings per share therefore indicates how much revenue Genic Co has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
3 years
5 years
10 years
Max
Sales per Share
EBIT per share
Earnings per Share
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Genic Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Genic Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Genic Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Genic Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
Genic Co Revenue, EBIT and net profit per share
| Date | Genic Co Sales per Share | Genic Co EBIT per share | Genic Co Earnings per Share |
|---|---|---|---|
| 2023 | 4,094.18 undefined | -586.81 undefined | -643.32 undefined |
| 2022 | 4,587.05 undefined | -462.85 undefined | -487.17 undefined |
| 2021 | 5,602.15 undefined | -575.24 undefined | -631.65 undefined |
| 2020 | 6,018.86 undefined | 148.57 undefined | -621.86 undefined |
| 2019 | 6,164.43 undefined | -163.86 undefined | -1,708.43 undefined |
| 2018 | 9,861 undefined | -1,630 undefined | -2,189 undefined |
| 2017 | 9,241.43 undefined | -1,183.71 undefined | -1,066.71 undefined |
| 2016 | 12,809.71 undefined | 765.71 undefined | 175 undefined |
| 2015 | 10,529.43 undefined | 445.57 undefined | 417.86 undefined |
| 2014 | 9,074.29 undefined | 273.43 undefined | 279.43 undefined |
| 2013 | 8,882.71 undefined | 552.43 undefined | 493.14 undefined |
| 2012 | 14,301.83 undefined | 1,184.83 undefined | 946.5 undefined |
| 2011 | 17,546 undefined | 2,270.33 undefined | 1,753.33 undefined |
| Sales per Share | EBIT per share | Earnings per Share | |
|---|---|---|---|
| 2011 | 17,546 KRW | 2,270.33 KRW | 1,753.33 KRW |
| 2012 | 14,301.83 KRW | 1,184.83 KRW | 946.5 KRW |
| 2013 | 8,882.71 KRW | 552.43 KRW | 493.14 KRW |
| 2014 | 9,074.29 KRW | 273.43 KRW | 279.43 KRW |
| 2015 | 10,529.43 KRW | 445.57 KRW | 417.86 KRW |
| 2016 | 12,809.71 KRW | 765.71 KRW | 175 KRW |
| 2017 | 9,241.43 KRW | -1,183.71 KRW | -1,066.71 KRW |
| 2018 | 9,861 KRW | -1,630 KRW | -2,189 KRW |
| 2019 | 6,164.43 KRW | -163.86 KRW | -1,708.43 KRW |
| 2020 | 6,018.86 KRW | 148.57 KRW | -621.86 KRW |
| 2021 | 5,602.15 KRW | -575.24 KRW | -631.65 KRW |
| 2022 | 4,587.05 KRW | -462.85 KRW | -487.17 KRW |
| 2023 | 4,094.18 KRW | -586.81 KRW | -643.32 KRW |
Genic Co business model
Genic Co is one of the most popular companies on Eulerpool.com.
Genic Co valuation based on historical P/E ratio, EBIT, and P/S ratio.
Genic Co shares outstanding KR7123330003 ·
The number of shares was Genic Co in 2023 — This indicates how many shares 6.856 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Genic Co earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Genic Co's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Genic Co’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Genic Co's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2011 | 6 M Aktien |
| 2012 | 6 M Aktien |
| 2013 | 7 M Aktien |
| 2014 | 7 M Aktien |
| 2015 | 7 M Aktien |
| 2016 | 7 M Aktien |
| 2017 | 7 M Aktien |
| 2018 | 7 M Aktien |
| 2019 | 7 M Aktien |
| 2020 | 7 M Aktien |
| 2021 | 6.86 M Aktien |
| 2022 | 6.86 M Aktien |
| 2023 | 6.86 M Aktien |
Genic Co Stock splits
In Genic Co's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Genic Co.
Genic Co Earnings Surprises
| Date | EPS Estimate | EPS Actual | Quarterly report |
|---|---|---|---|
| 12/31/2016 | 288.19 | -156.39 (-154.27 %) | 2016 Q4 |
| 9/30/2016 | 194.03 | 112.06 (-42.24 %) | 2016 Q3 |
| 6/30/2016 | 110.33 | 726.77 (558.72 %) | 2016 Q2 |
| 9/30/2014 | 108.72 | 39.3 (-63.85 %) | 2014 Q3 |
| 6/30/2014 | 45.73 | -43.57 (-195.27 %) | 2014 Q2 |
| 3/31/2014 | 67.3 | -42.72 (-163.47 %) | 2014 Q1 |
| 12/31/2013 | 73.34 | 153.78 (109.67 %) | 2013 Q4 |
1
Genic Co Stock Shareholders
% | Name | Stocks | Change | Date |
|---|---|---|---|---|
| 5.29 % | Medi Futures Co., Ltd. | 362,826 | 0 | 9/30/2023 |
| 26.03 % | SoulBrain Holdings Co Ltd | 1,784,441 | 0 | 9/30/2023 |
1
Genic Co stock: Frequently Asked Questions
What is the P/S ratio of Genic Co 2024?
The P/S cannot be calculated for Genic Co currently.
What is the AlleAktien quality score of Genic Co?
The AlleAktien quality score for Genic Co is 2/10.
What is the revenue of Genic Co 2024?
The revenue cannot currently be calculated for Genic Co.
How high is the profit of Genic Co 2024?
The profit cannot currently be calculated for Genic Co.
What is the business model of Genic Co
No history available for Genic Co.
What is the Genic Co dividend?
Genic Co pays a dividend of 0 KRW distributed over payouts per year.
How often does Genic Co pay dividends?
The dividend cannot currently be calculated for Genic Co or the company does not pay out a dividend.
What is the Genic Co ISIN?
The ISIN of Genic Co is KR7123330003.
What is the Genic Co ticker?
The ticker of Genic Co is 123330.KQ.
How much dividend does Genic Co pay?
Over the past 12 months, Genic Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Genic Co is expected to pay a dividend of 0 KRW.
What is the dividend yield of Genic Co?
The current dividend yield of Genic Co is .
When does Genic Co pay dividends?
Genic Co pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Genic Co?
Genic Co paid dividends every year for the past 0 years.
What is the dividend of Genic Co?
For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.
In which sector is Genic Co located?
Genic Co is assigned to the 'Non-cyclical consumption' sector.
Wann musste ich die Aktien von Genic Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Genic Co from 7/4/2024 amounting to 0 KRW, you needed to have the stock in your portfolio before the ex-date on 7/4/2024.
When did Genic Co pay the last dividend?
The last dividend was paid out on 7/4/2024.
What was the dividend of Genic Co in the year 2023?
In the year 2023, Genic Co distributed 0 KRW as dividends.
In which currency does Genic Co pay out the dividend?
The dividends of Genic Co are distributed in KRW.
Genic Co stock price, news, forecast, analysis
Sector
Non-cyclical consumption
Industry
Personal Care Products
Number of shares
Employee
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website
Country
South Korea 🇰🇷
Currency
KRW
Initial public offering
Aug 3, 2011
GOSIN
Global Open Securities Identification Number
Cusip
Y2693Y106
Market capitalization
PEG
0
P/E
Forward P/E
0
P/S
Forward P/S
0
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC
Scalable Capital savings plan Nein
Trade Republic savings plan Nein
comdirect savings plan
Consorsbank savings plan Nein
ING savings plan Nein
Genic Co Peer Group
Genic Co Eulerpool News
Genic Co News
Genic Co FIGI
| Genic Co Ticker | Genic Co FIGI |
|---|---|
| 123330:KS | BBG001LVGMH1 |
| 123330:KQ | BBG001R34SP8 |
Other fundamentals and analyses of Genic Co in the deep dive.
Our stock analysis for Genic Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Genic Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.